Archives for April 2020

MolecularMatch Releases Free COVID-19 and Coronavirus Trial Tracking Tool

by

MolecularMatch Releases Free COVID-19 and Coronavirus Trial Tracking Tool

HOUSTON, TX, April 14, 2020 – MolecularMatch, a leading clinical informatics company, has released a free, web-based portal to help researchers, physicians and patients find clinical trials for COVID-19 and coronavirus. The portal, available at VirusTrials.com, includes over 800 clinical trials across the globe for therapies and vaccines being tested for COVID-19. Physicians and patients can use their country, state or postal code to find enrolling trials nearest to the patient. Specific patient age, symptoms, severity and comorbidities are used to help find trials best suited to that individual. In addition to trials, the portal can also be used to search for literature and publications related to COVID-19.

“The number of therapeutic cures and vaccines being tested are growing at an astounding rate,” said Eric Pulaski, CEO at MolecularMatch. “Our tools make it easier for clinicians and patients to find the help they need. Hopefully, we can help save lives by shortening the time it takes to get more patients into clinical trials and by speeding up research to find cures and vaccines.”

MolecularMatch is providing the tool as a free public service in hopes of placing thousands of patients into trials as quickly as possible and saving researchers’ valuable time. Using the company’s highly-automated, AI-based curation platform, both the clinical trials database (currently, over 800) and publications (currently, over 2,400) are being updated every 2-3 days.

About MolecularMatch

MolecularMatch, Inc. is a Houston, Texas based clinical informatics SaaS company established in 2014. The company was founded on the vision of using tumor molecular profiling and outcomes from previously-treated patients to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include molecular labs, health information systems, biopharma, second opinion and payer companies, as well cancer centers on a global basis. Visit us at molecularmatch.com or follow us on Twitter or LinkedIn.

MolecularMatch Releases Support for Coronavirus New v4.1 Adds Search Results for COVID-19 Clinical Trials and Publications

by

MolecularMatch Releases Support for Coronavirus

New v4.1 Adds Search Results for COVID-19 Clinical Trials and Publications

HOUSTON, TX, April 6, 2020 – MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions, has updated the MolecularMatch search engine with new features and content to support customers’ response to the novel coronavirus pandemic. Updates include access to hundreds of clinical trials and thousands of publications that are applicable to coronavirus and COVID-19.

With the built-in search features of the MolecularMatch search engine, users can locate the most appropriate clinical trials and publications for individual patients, including filtering clinical trials for inclusion and exclusion criteria based on patient-specific clinical details and narrowing search results to trial sites by a patent’s geographic location. Institutions can also upload private trials to the MolecularMatch database that are not yet indexed in the public registries.

“Our team has been working overtime to add support for coronavirus and COVID-19 clinical trials and publications,” said Eric Pulaski, CEO of MolecularMatch. “Although the focus of our curated content has been on oncology, the versatility of our core platform enabled us to quickly add support for new content in this area of infectious disease. We’re stepping up to the plate to do our part to support researchers, labs, healthcare providers, and others in the global fight against the novel Coronavirus pandemic.”

Version 4.1 of the company’s web-based portal (MMPortal) and REST API (MMPower) are available immediately, and all current customers have access to the new content at no additional charge. The MolecularMatch Knowledge Graph and content across the MolecularMatch knowledgebase have been enhanced with the following:

  • Added support for antiviral drugs and drug classes
  • Added virology, emergency medicine and infectious disease related journals and publications (over 2,300 publication entries)
  • Added global registry clinical trials related to coronavirus/COVID-19 (over 360 trials)
  • MolecularMatch’s clinical comprehension and ranking applied to this new data

The MolecularMatch COVID-19 database is updated every 2-3 days. The company is also exploring other ways to help battle this pandemic with new offerings to reach a wider base of users who can benefit from the MolecularMatch search engine.

About MolecularMatch

MolecularMatch, Inc. is a Houston, Texas based clinical informatics SaaS company established in 2014. The company was founded on the vision of using tumor molecular profiling and outcomes from previously-treated patients to provide the best personalized treatment for current patients. MolecularMatch delivers personalized, evidence-based therapeutic guidance and clinical trials matched to each patient. Customers include molecular labs, health information systems, biopharma, second opinion and payer companies, as well as cancer centers across the globe. Visit us at molecularmatch.com or follow us on Twitter or LinkedIn.